“Our results have started unraveling the brain mechanisms of a new drug that works in a completely different way to traditional antipsychotics,” lead researcher Dr. Sagnik Bhattacharyya told British newspaper The Independent.

“One of the reasons CBD is exciting is because it is very well tolerated compared to the other anti-psychotics we have available.”

The newspaper also reported that the Institute of Psychiatry, Psychology and Neuroscience at King’s College is planning another clinical trial to test the true potential of CBD as a treatment and has already begun recruiting the 300 participants needed for the study. 

While there have been several studies that suggest a link between chronic cannabis use and mental illness, Dr. Bhattacharyya and his team are furthering the possibility that cannabis has positive applications for certain serious conditions.